Duane Reade to provide HP photo publishing solutions throughout its stores
NEW YORK Duane Reade has inked a new agreement with HP to expand a 2008 pilot program in select stores and install HP Photo Center solutions in more than 200 locations in the greater New York City area.
“Our brand is all about New York living made easy,” stated Joe Magnacca, chief merchandising offer for Duane Reade. “Making this level of quality digital photofinishing convenient through HP kiosks and full-service counters across 200 of our stores is one more way we can be relevant and helpful to our customers on a daily basis. We’re very happy when we can partner with the best to make life easier for New Yorkers.”
The HP Photo Center solutions will enable customers to order photos and create a variety of photo products, such as photo books, calendars, greeting cards and posters. The pilot stores achieved up to 50% year-over-year improvement versus the chain-wide average in the in-store photo category, the company stated.
Under the new agreement, Duane Reade will install a customized mix of HP Retail Publishing Solutions across its stores. In the middle- to high-volume stores, the HP Photo Center provides front- and back-of-counter operations to allow customers to order instant 4-in. x 6-in. and 5-in. x 7-in. prints, 8-in. x 10-in. enlargements and such products as photo books, calendars, greeting cards, posters and 100-year archive DVDs.
In non-photo lab stores, customers will be able to use the HP Photosmart Express instant-print kiosk — a standalone, self-serve solution designed to produce 4-in. x 6-in. prints and photo CDs.
Acetaminophen products to undergo changes following advisory committee’s votes
ADELPHI, Md. Three Food and Drug Administration advisory committees voted on sweeping changes regarding the marketing, merchandising and formulation of acetaminophen products last week, though the proposed changes fell short of pulling combination products containing APAP off the market.
Among the changes: committee members recommend by a vote of 21-16 that the maximum total daily dose of 4 grams/day of APAP in nonprescription single ingredient and combination products be lowered; 24-13 recommended the maximum nonprescription single adult dose be limited to 650 mg; 26-11 recommended that acetaminophen doses above that be reverse-switched to prescription-only; and 36-1 suggested that only one strength of APAP in liquid form be available OTC.
However, advisory committee members recommended against imposing pack-size limitations on products containing acetaminophen (17-20); and the committee also did not support the recall of OTC APAP combination products (13-24).
On that note, OTC manufacturers of APAP products breathed a sigh of relief. “[The Consumer Healthcare Products Association] strongly believes that patients and physicians should continue to have access to the current range of over-the-counter acetaminophen-containing products, and we are pleased the committee did not recommend eliminating these important nonprescription products,” Linda Suydam, CHPA president, stated following the meeting. “While we are pleased with the committee’s recommendation to allow continued access to OTC combination medicines containing acetaminophen because we know they provide real benefits to consumers, we are disappointed in their divided vote to lower the maximum daily dose and the single dose of 1,000 mg acetaminophen,” she added.
According to CHPA, there was a notable lack of data referenced by the committee to support these recommendations.
Kicking the habit with Nicorette
NEW YORK First, it’s the first truly “new” product to enter the smoking cessation space in quite some time, featuring a strong point-of-differentiation (convenience packaging; faster efficacy), versus products already in this space.
Second, smoking cessation is about to explode, especially as President Barack Obama last month signed into law the Family Smoking Prevention and Tobacco Control Act of 2009, which cedes regulation of tobacco products to the Food and Drug Administration. The law may not ban cigarettes today, or even tomorrow, but it just placed a product long considered a public-health hazard into the regulatory hands of an agency charged with “protecting the public health by assuring the safety, efficacy and security of [medicines], medical devices, our nation’s food supply, cosmetics and products that emit radiation.”
The Congressional Budget Office predicts the new law will decrease adult smoking by 2%, independent of reductions in use that result from higher excise taxes and public smoking restrictions.
More than half of the close-to 50 million smokers attempt to quit each year — 70% of successful ex-smokers made one or two attempts; 22% made between three and five attempts; and 9% quit six or more times before succeeding.
And finally, earlier this month two prescription-only smoking-cessation drugs will now carry a black-boxed warning around the risk of mental health problems in patients taking the drugs.
New product with new features plus increased smoking cessation regulation plus black-boxed warnings for the more popular prescription smoking-cessation medicines all equals a potential new homerun in the smoking cessation category.